Hexaminolevulinate Hydrochloride
This is the hydrochloride salt form of hexaminolevulinate, a photosensitizing diagnostic agent used to enhance the detection of bladder cancer during fluorescence cystoscopy. Cancer cells absorb and metabolize it more actively than normal cells, making them fluoresce under special blue light. The hydrochloride salt form ensures solubility for bladder instillation.
Moleküler Ağırlık
251,7500 g/mol
TPSA
69,40 Ų
Terapötik Alanlar
Etki Mekanizması
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
2D Yapı
Cite this structure
Embed this structure
SMILES
CCCCCCOC(=O)CCC(=O)CN.Cl
InChI
InChI=1S/C11H21NO3.ClH/c1-2-3-4-5-8-15-11(14)7-6-10(13)9-12;/h2-9,12H2,1H3;1H
Molecular Formula
C11H22ClNO3
HBD / HBA
2 / 4
Döndürülebilir Bağlar
10
Ağır Atomlar
16
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
This is the hydrochloride salt form of hexaminolevulinate, a photosensitizing diagnostic agent used to enhance the detection of bladder cancer during fluorescence cystoscopy. Cancer cells absorb and metabolize it more actively than normal cells, making them fluoresce under special blue light. The hydrochloride salt form ensures solubility for bladder instillation.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Hexaminolevulinate Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201785. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 6433082. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="hexaminolevulinate-hydrochloride"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/hexaminolevulinate-hydrochloride/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/hexaminolevulinate-hydrochloride/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/hexaminolevulinate-hydrochloride/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="hexaminolevulinate-hydrochloride"></drugfyi-drug>